Investors
Careers
Contact Us
About Us
Our Products
Our Pipeline
Our Technology
Stock
Nasdaq:
DEPO
Price:
3.86 +0.00
Volume:
0
20 minute delay
In The News
September 9, 2010
Depomed to Present at the Rodman & Renshaw 12th Annual Healthcare Conference
August 11, 2010
Depomed Reaches SPA Agreement With FDA for Phase 3 Hot Flash Trial
August 5, 2010
Depomed Licenses GLUMETZA(R) Data and Acuform(R) Technology
August 5, 2010
Depomed Reports Second Quarter 2010 Financial Results
August 3, 2010
Depomed Receives Confirmation from Pfizer That No Infringement Suit to be Filed on DM-1796 NDA